The President of the European Central Bank believes that Europe needs to reshape its economy to cope with international changes.
Cristina Petrache
Economy
Foto Eibner-Pressefoto/Florian Wiegand / imago stock&people / Profimedia
Always see our news on Google
Christine Lagarde, the president of the European Central Bank, stated that she expects a slight inflationary effect due to the tariffs announced by the USA, with a more pronounced impact on Germany than on France. With inflation under control at 1.9%, Lagarde believes the effect will be minimal, but she emphasized the seriousness of the uncertainty generated by these trade measures. American President Donald Trump announced tariffs for several European countries, a gesture perceived by the EU as a disadvantage. Lagarde highlighted the importance of European unity and determination in the face of these trade challenges. She also mentioned that she will closely monitor Trump's speech at the Davos Forum, believing that his position will influence the European reaction.
Sources
Lagarde avertizează: Europa trebuie să-și regândească economia pentru a răspunde presiunilor globale
Christine Lagarde solicită o revizuire profundă a economiei europene pentru a face faţă noii ordini mondiale
Noua ordine mondială – Europa are nevoie de o „reformă profundă” a economiei pentru a face faţă schimbărilor la nivel internaţional, spune Lagarde
Latest News
08:06
The U.S. Treasury debt has reached $40.047 trillion, exceeding CBO estimates. The rapid increase in the deficit raises concerns in the financial markets.
07:59
The Washington Post: Russians withdraw billions from banks, fearing that Putin will confiscate their deposits to finance his war
07:46
Hungary: The construction of a riverbed threshold on the Danube has raised the water level by 15-20 cm, preventing the shutdown of the turbines at the Paks nuclear power plant.
07:45
Kiev was the target of a new attack with Russian ballistic missiles. At least six people have died and 12 have been injured.
07:37
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
